Home Page
11:30:31 EST Fri 21 Nov 2014
Enter Symbol
or Name
USA
CA



WARNER CHILCOTT PLC ORD CL A IRE
Symbol U : WCRX
Recent Sedar Documents

Warner Chilcott Announces Earnings Release Date and Conference Call for Fourth Quarter and Full Year 2012 Financial Results

2013-02-18 16:15 ET - News Release

DUBLIN, Ireland, Feb. 18, 2013 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that it will issue its fourth quarter and full year 2012 financial results prior to the market opening on Friday, February 22, 2013.

In addition to issuing a press release, the Company will host a conference call for all interested parties on Friday, February 22, 2013 at 8:00 AM (Eastern Time) to review the results. To participate in the call, please dial (877) 354-4056 in the United States and Canada or (678) 809-1043 internationally.

Investors and other interested parties may also access the conference call via a simultaneous audio webcast by visiting http://ir.wcrx.com and clicking on Events & Presentations.

A replay of the conference call will be available for two weeks following the call and can be accessed by dialing (800) 585-8367 within the United States and Canada or (404) 537-3406 internationally. The passcode for the replay is 93788873.

The Company

Warner Chilcott is a leading specialty pharmaceutical company currently focused on the women's healthcare, gastroenterology, urology and dermatology segments of the branded pharmaceuticals market, primarily in North America. We are a fully integrated company with internal resources dedicated to the development, manufacture and promotion of our products. WCRX-F

CONTACT: Company Contact:
         Rochelle Fuhrmann
         Investor Relations
         973-442-3281
         rfuhrmann@wcrx.com

© 2014 Canjex Publishing Ltd. All rights reserved.